跳至主要内容
临床试验/NCT05512286
NCT05512286招募中不适用

Comparison of Patient-Reported Outcome and Safety Outcomes Between Preoperative and Postmastectomy Radiotherapy in Breast Cancer Patients with Reconstruction of DIEP Flap: a Multicenter,Prospective,Open-label,Randomized Controlled Trial

Fudan University6 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年8月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
80
试验地点
6
主要终点
Patient satisfaction with breasts questionnaire Patient satisfaction of breast

研究概览

简要总结

This study is the first prospective randomized study assessing the patient-reported outcomes and safety outcomes between preoperative and postmastectomy radiotherapy in locally advanced breast cancer patients with immediate reconstruction of deep inferior epigastric perforator(DIEP) flap. Radiotherapy before mastectomy and autologous free-flap breast reconstruction can avoid adverse radiation effects on healthy donor tissues and delays to adjuvant radiotherapy. We aimed to explore the feasibility of preoperative radiotherapy followed by DIEP flap reconstruction in patients with breast cancer requiring mastectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with histological proven invasive breast cancer;
  • Clinical T0-3, T4b and N0-3a disease who require neoadjuvant chemotherapy;
  • No distant metastasis;
  • Adjuvant radiotherapy and who are suitable for DIEP flap reconstruction at the time of mastectomy.

排除标准

  • Patients enrolled in other clinical trial which may as influence the outcome;
  • Patients received neoadjuvant therapy without radiotherapy indications;
  • Disease progression during neoadjuvant chemotherapy;
  • Patients of pregnancy or lactation;
  • Previous history of diabetes;
  • Previous history of heavy smoking.

结局指标

主要结局

Patient satisfaction with breasts questionnaire Patient satisfaction of breast

时间窗: 24 months after surgery

Patient satisfaction with breasts (as measured using the BREAST-Q reconstruction module) 24 months after surgery.

次要结局

  • Complications of radiotherapy(3 months, 12 months, and 24 months after radiotherapy)
  • Failure rate of breast reconstruction surgery(8 weeks after surgery)
  • Patient satisfaction with outcome questionnaire(3months, 12 months, and 24 months after surgery)
  • Aesthetic evaluation(12 months and 24 months after surgery)
  • Total pathologic complete response (tpCR)(up to 4 weeks after surgery)
  • Complications of surgery(3 months, 12 months, and 24 months)
  • 3-year disease free survival (DFS)(3 years after diagnosis)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiong Wu

Professor

Fudan University

研究点 (6)

Loading locations...

相似试验